286 related articles for article (PubMed ID: 24993292)
1. Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin- and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients.
Segovia-Gamboa N; Rodríguez-Arellano ME; Rangel-Cruz R; Sánchez-Díaz M; Ramírez-Reyes JC; Faradji R; González-Domínguez É; Sánchez-Torres C
Clin Immunol; 2014 Sep; 154(1):72-83. PubMed ID: 24993292
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
Torres-Aguilar H; Blank M; Kivity S; Misgav M; Luboshitz J; Pierangeli SS; Shoenfeld Y
Ann Rheum Dis; 2012 Jan; 71(1):120-8. PubMed ID: 21914629
[TBL] [Abstract][Full Text] [Related]
3. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
4. Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K; Grohová A; Strnadová P; Funda DP; Šumník Z; Lebl J; Cinek O; Průhová Š; Koloušková S; Obermannová B; Petruželková L; Šedivá A; Fundová P; Buschard K; Špíšek R; Palová-Jelínková L
J Immunol; 2017 Jan; 198(2):729-740. PubMed ID: 27927966
[TBL] [Abstract][Full Text] [Related]
5. IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals.
Torres-Aguilar H; Sánchez-Torres C; Jara LJ; Blank M; Shoenfeld Y
J Clin Immunol; 2010 Sep; 30(5):659-68. PubMed ID: 20544263
[TBL] [Abstract][Full Text] [Related]
6. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop.
Nagata M; Kotani R; Moriyama H; Yokono K; Roep BO; Peakman M
Ann N Y Acad Sci; 2004 Dec; 1037():10-5. PubMed ID: 15699487
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
9. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
[TBL] [Abstract][Full Text] [Related]
10. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
[TBL] [Abstract][Full Text] [Related]
12. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
14. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
15. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
16. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects.
Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS
Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
18. A low antigen dose selectively promotes expansion of high-avidity autoreactive T cells with distinct phenotypic characteristics: a study of human autoreactive CD4+T cells specific for GAD65.
Oling V; Geubtner K; Ilonen J; Reijonen H
Autoimmunity; 2010 Dec; 43(8):573-82. PubMed ID: 20370569
[TBL] [Abstract][Full Text] [Related]
19. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.
Danke NA; Yang J; Greenbaum C; Kwok WW
J Autoimmun; 2005 Dec; 25(4):303-11. PubMed ID: 16249070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
